Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
123 people get MAXY articles and Market Currents by email alert.
Get email alerts on MAXY »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
Business Wire (May 3, 2013)
-
Business Wire (Mar 12, 2013)
-
Business Wire (Jan 29, 2013)
-
Business Wire (Nov 6, 2012)
-
-
-
-
Business Wire (Aug 7, 2012)
-
Business Wire (May 14, 2012)
-
Business Wire (May 7, 2012)
-
Maxygen: Bayer $30 Million Payment Likely In 2012Apsara Biotechnology Research • Wed, May 2, 2012 -
-
Maxygen: A Biotech Play With Low Downside - Part 1Apsara Biotechnology Research • Thu, Mar 1, 2012
-
2012's Low P/E StocksValue Research • Tue, Jan 10, 2012 -
Business Wire (Jan 10, 2012)
-
-
-
-
To learn more about Seeking Alpha Pro, click here.
-
Maxygen: Bayer $30 Million Payment Likely In 2012Apsara Biotechnology Research • Wed, May 2, 2012
-
-
Maxygen: A Biotech Play With Low Downside - Part 1Apsara Biotechnology Research • Thu, Mar 1, 2012
-
Quick Take: Maxygen, Inc.MagicDiligence • Fri, Feb 6, 2009
-
-
-
-
-
2012's Low P/E StocksValue Research • Tue, Jan 10, 2012
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Maxygen, Inc. Q4 2008 Earnings Call TranscriptTue, Feb 10, 2009
-
Maxygen Inc Q3 2008 Earnings Call TranscriptTue, Nov 4, 2008
-
Maxygen, Inc. Q2 2008 Earnings Conference Call TranscriptThu, Jul 31, 2008
-
Maxygen, Inc., Q1 2008 Earnings Call TranscriptTue, May 6, 2008
-
Maxygen Inc. Q4 2007 Earnings Call TranscriptTue, Feb 12, 2008
-
Business Wire (May 3, 2013)
-
Business Wire (Mar 12, 2013)
-
Business Wire (Jan 29, 2013)
-
Business Wire (Nov 6, 2012)
-
at MarketWatch.com (Aug 8, 2012)
-
Business Wire (Aug 7, 2012)
-
Business Wire (May 14, 2012)
-
Business Wire (May 7, 2012)
-
Business Wire (Jan 10, 2012)
-
at MarketWatch.com (Mar 17, 2011)
-
at MarketWatch.com (Dec 15, 2010)
-
at MarketWatch.com (Dec 15, 2010)
-
at MarketWatch.com (Nov 23, 2010)
MAXY vs. ETF Alternatives
Company Description
Currently, there's no company description for MAXY.
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Monday, October 10, 2011, 6:39 PM Maxygen (MAXY) gains in the post-session after it says the U.S. Patent and Trademark Office has rejected all of Amgen's (AMGN) patent claims to certain molecules that potentially cover Maxygen's MAXY-G34 drug candidate. MAXY +3.2% AH. Comment! [On the Move, Healthcare]
-
Wednesday, December 15, 2010, 9:00 AM
Premarket gainers: ARAY +13%. CYPB +13%. SHZ +8%. NVS +8%. RF +7%. JOYG +5%. DYN +5%. MCP +4%. REE +4%.
Losers: MAXY -27%. AIB -5%. IVR -4%. Comment!
-
MagicDiligence
New article: Watch out for the "one-time revenue effect" with Magic Formula stocks. $LMLP $MAXY $POZN $MBLX http://bit.ly/SKQsbb - View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
LATEST REPLIES